Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation

被引:55
作者
Calao, M. [1 ]
Sekyere, E. O. [1 ]
Cui, H. J. [2 ]
Cheung, B. B. [1 ]
Thomas, W. D. [1 ]
Keating, J. [1 ]
Chen, J. B. [1 ]
Raif, A. [1 ]
Jankowski, K. [1 ]
Davies, N. P. [1 ]
Bekkum, M. V. [1 ]
Chen, B. [1 ]
Tan, O. [1 ]
Ellis, T. [3 ]
Norris, M. D. [1 ]
Haber, M. [1 ]
Kim, E. S. [4 ]
Shohet, J. M. [4 ]
Trahair, T. N. [1 ,5 ]
Liu, T. [1 ]
Wainwright, B. J. [3 ]
Ding, H. F. [6 ]
Marshall, G. M. [1 ,5 ]
机构
[1] Univ New S Wales, Lowy Canc Res Ctr, Childrens Canc Inst Australia Med Res, Sydney, NSW 2031, Australia
[2] Southwest Univ, Inst Sericulture & Syst Biol, State Key Lab Silkworm Funct Genome Biol, Chongqing, Peoples R China
[3] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia
[4] Texas Childrens Hosp, Houston, TX 77030 USA
[5] Sydney Childrens Hosp, Sydney, NSW, Australia
[6] Med Coll Georgia, Augusta, GA 30912 USA
基金
英国医学研究理事会;
关键词
Bmi1; p53; MYCN; neuroblastoma; medulloblastoma; apoptosis; MYC TRANSGENIC MICE; STEM-CELLS; IN-VIVO; NEUROBLASTOMA; MEDULLOBLASTOMA; LINES; AMPLIFICATION; EXPRESSION; MECHANISM; APOPTOSIS;
D O I
10.1038/onc.2012.368
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Embryonal cancer can arise from postnatally persistent embryonal remnant or rest cells, which are uniquely characterized by the absence of p53 mutations. Perinatal overexpression of the MycN oncoprotein in embryonal cancer precursor cells causes postnatal rests, and later tumor formation through unknown mechanisms. However, overexpression of Myc in adult tissues normally activates apoptosis and/or senescence signals as an organismal defense mechanism against cancer. Here, we show that perinatal neuroblastoma precursor cells exhibited a transiently diminished p53 response to MycN oncoprotein stress and resistance to trophic factor withdrawal, compared with their adult counterpart cells from the TH-MYCN-/- transgenic mouse model of neuroblastoma. The adult stem cell maintenance factor and Polycomb group protein, Bmi1 (B-cell-specific Moloney murine leukemia virus integration site), had a critical role at neuroblastoma initiation in the model, by repressing p53 responses in precursor cells. We further show in neuroblastoma tumor cells that Bmi1 could directly bind p53 in a complex with other Polycomb complex proteins, Ring1A or Ring1B, leading to increased p53 ubiquitination and degradation. Repressed p53 signal responses were also seen in precursor cells for other embryonal cancer types, medulloblastoma and acute lymphoblastic leukemia. Collectively, these date indicate a general mechanism for p53 inactivation in some embryonal cell types and consequent susceptibility to MycN oncogenesis at the point of embryonal tumor initiation.
引用
收藏
页码:3616 / 3626
页数:11
相关论文
共 47 条
[1]   Targeted depletion of BMI1 sensitizes tumor cells to P53-mediated apoptosis in response to radiation therapy [J].
Alajez, N. M. ;
Shi, W. ;
Hui, A. B. Y. ;
Yue, S. ;
Ng, R. ;
Lo, K-W ;
Bastianutto, C. ;
O'Sullivan, B. ;
Gullane, P. ;
Liu, F-F .
CELL DEATH AND DIFFERENTIATION, 2009, 16 (11) :1469-1479
[2]   The E3 Ubiquitin-Ligase Bmi1/Ring1A Controls the Proteasomal Degradation of Top2α Cleavage Complex - A Potentially New Drug Target [J].
Alchanati, Iris ;
Teicher, Carmit ;
Cohen, Galit ;
Shemesh, Vivian ;
Barr, Haim M. ;
Nakache, Philippe ;
Ben-Avraham, Danny ;
Idelevich, Anna ;
Angel, Itzchak ;
Livnah, Nurit ;
Tuvia, Shmuel ;
Reiss, Yuval ;
Taglicht, Daniel ;
Erez, Omri .
PLOS ONE, 2009, 4 (12)
[3]  
BECKWITH JB, 1963, AM J PATHOL, V43, P1089
[4]   Neuroblastoma: Biological insights into a clinical enigma [J].
Brodeur, GM .
NATURE REVIEWS CANCER, 2003, 3 (03) :203-216
[5]   Structure and E3-ligase activity of the Ring-Ring complex of polycomb proteins Bmi1 and Ring1b [J].
Buchwald, Gretel ;
van der Stoop, Petra ;
Weichenrieder, Oliver ;
Perrakis, Anastassis ;
van Lohuizen, Maarten ;
Sixma, Titia K. .
EMBO JOURNAL, 2006, 25 (11) :2465-2474
[6]   Increased frequency of aberrations in the p53/MDM2/p14ARF pathway in neuroblastoma cell lines established at relapse [J].
Carr, J ;
Bell, E ;
Pearson, ADJ ;
Kees, UR ;
Beris, H ;
Lunec, J ;
Tweddle, DA .
CANCER RESEARCH, 2006, 66 (04) :2138-2145
[7]   p53 Is a Direct Transcriptional Target of MYCN in Neuroblastoma [J].
Chen, Lindi ;
Iraci, Nunzio ;
Gherardi, Samuele ;
Gamble, Laura D. ;
Wood, Katrina M. ;
Perini, Giovanni ;
Lunec, John ;
Tweddle, Deborah A. .
CANCER RESEARCH, 2010, 70 (04) :1377-1388
[8]   Mdm2 Deficiency Suppresses MYCN-Driven Neuroblastoma Tumorigenesis In Vivo [J].
Chen, Zaowen ;
Lin, Yunfu ;
Barbieri, Eveline ;
Burlingame, Sue ;
Hicks, John ;
Ludwig, Andrew ;
Shohet, Jason M. .
NEOPLASIA, 2009, 11 (08) :753-762
[9]   Cell lines from MYCN transgenic murine turnours reflect the molecular and biological characteristics of human neuroblastorna [J].
Cheng, Andy J. ;
Cheng, Ngan Ching ;
Ford, Jette ;
Smith, Janice ;
Murray, Jayne E. ;
Flemming, Claudia ;
Lastowska, Maria ;
Jackson, Michael S. ;
Hackett, Christopher S. ;
Weiss, William A. ;
Marshall, Glenn M. ;
Kees, Ursula R. ;
Norris, Murray D. ;
Haber, Michelle .
EUROPEAN JOURNAL OF CANCER, 2007, 43 (09) :1467-1475
[10]   Chemotherapy-Induced Apoptosis in a Transgenic Model of Neuroblastoma Proceeds Through p53 Induction [J].
Chesler, Louis ;
Goldenberg, David ;
Collins, Rodney ;
Grimmer, Matt ;
Kim, Grace E. ;
Tihan, Tarik ;
Nguyen, Kim ;
Yakovenko, Slava ;
Matthay, Katherine K. ;
Weiss, William A. .
NEOPLASIA, 2008, 10 (11) :1268-U93